The Food and Drug Administration (FDA) has approved Besponsa (inotuzumab ozogamicin) for pediatric patients 1 year and older with relapsed or refractory ...

The FDA will OKed a phase 1 trial to investigate a novel cancer vaccine for certain patients with ovarian cancer. The Food and Drug Administration (FDA) has ...

In one sense, it’s a revolutionary step forward. In another, it’s what we’ve always been doing. As surely as children find strange things in their ...

Immunotherapy may be boosted in some patients with rare cancers, depending on their gut microbiota.Certain strains of gut bacteria may boost immunotherapy ...

Facing up to cancer inequities SAMBAI, meanwhile, are taking on the cancer inequities challenge. They’ve been funded to see why different groups of ...

I'm Gonna Live Until I Die...You say I'm metastatic, and that I'm gonna die.But I prefer to be ecstatic... not make my loved ones cry.So don't harsh my ...

There are lots of things “everyone knows” about cancer. Many of them are correct. Some of them are correct for some people but not everyone. Some of them ...

The drug combination of Lutathera and Sandostatin showed promising outcomes in patients with advanced gastric neuroendocrine tumors.Patients with advanced ...

Improving survival outcomes for patients with pancreatic cancer is a complex task.A better understanding of the basic biology of the disease and more ...

In this special issue of CURE, we examine some of the latest developments in the treatment of ALK-positive non-small cell lung cancer (NSCLC). This subtype ...